SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000053417-10-000046
Filing Date
2010-02-12
Accepted
2010-02-12 14:02:12
Documents
1
Group Members
CUMBERLAND PHARMACEUTICALS ANNUAL 13G FILING

Document Format Files

Seq Description Document Type Size
1 CUMBERLAND PHARMACEUTICALS ANNUAL 13G FILING cpix1209.txt SC 13G 7133
  Complete submission text file 0000053417-10-000046.txt   9130
Mailing Address 466 LEXINGTON AVE NEW YORK NY 10017
Business Address 466 LEXINGTON AVE NEW YORK NY 10017 2124211000
JENNISON ASSOCIATES LLC (Filed by) CIK: 0000053417 (see all company filings)

IRS No.: 132631108 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Subject) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: SC 13G | Act: 34 | File No.: 005-85205 | Film No.: 10597510
SIC: 2834 Pharmaceutical Preparations